According to the research published in the New England Journal for Medicine, weight loss, which can only be achieved with weight loss surgery before, was achieved with medication for the first time.
The study, conducted with approximately 2,000 people in 16 countries with the participation of many universities in 68 weeks, showed that the drug Semaglutide is effective in the treatment of obesity.
The drug, which allows the body to take over the appetite regulator system of the brain, reduces the feeling of hunger and consequently calorie intake.
One of the authors of the study, University of London Academy Obesity Research Center President Prof. “Three-quarters of the people who took 2.4 mg of Semaglutide lost more than 10 percent of their body weight and a third more than 20 percent. No other drug has been able to lose that much weight. This is indeed a game changer.” ” said.
Participants in the study lost an average of 15.3 kg. Along with the weight loss, there was a decrease in risk factors for heart disease and diabetes, such as fat around the waist, fat in the blood, blood sugar and blood pressure. In addition, improvements were noted in the quality of life of the volunteers.
Semaglutide, produced by Novo Nordisk, is mainly used in the treatment of Type 2 diabetes.